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Abstract 
Background: Arcobacter (A.) butzleri has been described as causative agent for sporadic cases of human gastroenteri-
tis with abdominal pain and acute or prolonged watery diarrhea. In vitro studies revealed distinct adhesive, invasive 
and cytotoxic properties of A. butzleri. Information about the underlying immunopathological mechanisms of infec-
tion in vivo, however, are scarce. The aim of this study was to investigate the immunopathological properties of two 
different A. butzleri strains in a well-established murine infection model.
Results: Gnotobiotic IL-10−/− mice, in which the intestinal microbiota was depleted by broad-spectrum antibiotic 
treatment, were perorally infected with two different A. butzleri strains isolated from a diseased patient (CCUG 30485) 
or fresh chicken meat (C1), respectively. Eventhough bacteria of either strain could stably colonize the intestinal tract 
at day 6 and day 16 postinfection (p.i.), mice did not exert infection induced symptoms such as diarrhea or wasting. 
In small intestines of infected mice, however, increased numbers of apoptotic cells could be detected at day 16, but 
not day 6 following infection with either strain. A strain-dependent influx of distinct immune cell populations such as 
T and B cells as well as of regulatory T cells could be observed upon A. butzleri infection which was accompanied by 
increased small intestinal concentrations of pro-inflammatory cytokines such as TNF, IFN-γ, MCP-1 and IL-6. Remark-
ably, inflammatory responses following A. butzleri infection were not restricted to the intestinal tract, given that the 
CCUG 30485 strain induced systemic immune responses as indicated by increased IFN-γ concentrations in spleens at 
day 6, but not day 16 following infection.
Conclusion: Upon peroral infection A. butzleri stably colonized the intestinal tract of gnotobiotic IL-10−/− mice. The 
dynamics of distinct local and systemic inflammatory responses could be observed in a strain-dependent fash-
ion pointing towards an immunopathogenic potential of A. butzleri in vivo. These results indicate that gnotobiotic 
IL-10−/− mice are well suited to further investigate the molecular mechanisms underlying arcobacteriosis in vivo.
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Background
Arcobacter and Campylobacter share taxonomic rela-
tionship given that the genus Arcobacter belongs to the 
family of Campylobacteraceae [1]. So far, 18 distinct 
Arcobacter species have been described, isolated from 
a plethora of environments and hosts [1]. Whereas the 
motile, spiral-shaped and gram-negative Arcobacter spp. 
are mostly reported as gastrointestinal commensals in 
animals, the International Commission on Microbiologi-
cal Specifications for Foods has rated Arcobacter (A.) but-
zleri and A. cryaerophilus as serious hazards for human 
health [2]. Robust epidemiological data regarding preva-
lence and incidence of Arcobacter associated human dis-
eases are rather scarce, since in the vast majority of cases 
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Arcobacter spp. are not detected by routine diagnostic 
measures applied in conventional microbiology labora-
tories [1]. Retrospective studies, however, revealed that 
Arcobacter spp. are the fourth most common Campy-
lobacterales species recovered from patients suffering 
from diarrhea [3–7]. Consumption of contaminated food 
or water has been considered the most likely mode of 
transmission leading to Arcobacter induced disease out-
breaks [6, 8]. Arcobacteriosis is characterized by symp-
toms of acute gastroenteritis including abdominal pain, 
acute diarrhea or prolonged watery diarrhea for up to 
several weeks [5–7]. So far, only very limited informa-
tion is available about the underlying immunopathogenic 
mechanisms and responsible virulence genes of Arco-
bacter infection. Ten putative virulence genes, namely 
cadF, mviN, pldA, tlyA, cj1349, hecB, irgA, hecA, ciaB and 
iroE have been detected within the genomic sequence 
of A.  butzleri strain RM 4018 [9]. These virulence fac-
tors have been shown to contribute to adhesion (CadF, 
HecA, Cj1349), invasion (CiaB), lysis of erythrocytes 
(HecB, TlyA, PldA), iron acquisition and maintenance 
of infection (IrgA, IroE) and peptidoglycan biosynthesis 
(MviN) in other bacteria [10–18]. Nevertheless, it is still 
unknown whether these putative virulence factors exert 
similar functions in Arcobacter and whether further viru-
lence genes exist within these species. Phenotypic assays 
revealed that A. butzleri is able to adhere to and invade 
into several cell lines. However, there is no correlation 
between distinct virulence gene patterns of A. butzleri 
isolates and adhesive and invasive properties in vitro [19, 
20]. Also cytotoxic effects of several A. butzleri strains 
have been observed in vitro, but no corresponding toxin 
has been identified yet [4, 21–25].
Data regarding the immunopathological mechanisms 
underlying A. butzleri infection and the corresponding 
host responses are scarce and conflicting. In vivo stud-
ies revealed discrepant results so far, depending on the 
animal species, the breed and on the respective A. but-
zleri strain. For instance, A. butzleri was unable to infect 
conventional chicken and induce disease, whereas cer-
tain turkey strains could be colonized at different loads 
and displayed variable mortality rates [26]. Furthermore, 
in neonatal piglets A. butzleri displayed rather invasive 
properties and could also be isolated from extra-intesti-
nal compartments including kidney, liver and brain [27]. 
Whereas neonatal albino rats presented with self-limiting 
diarrhea and small intestinal as well as hepatic necrosis, 
adult rats exerted watery diarrhea and disturbed serum 
electrolyte balance in a pathogen-load-dependent man-
ner [28, 29].
Murine infection experiments with enteric pathogens 
such as Campylobacter jejuni are hampered by the physi-
ological colonization resistance exerted by conventionally 
colonized mice due to their distinct host- and age-spe-
cific microbiota composition [30]. We have previously 
reported that following depletion of the murine intes-
tinal microbiota in IL-10−/− mice by broad-spectrum 
antibiotic treatment, colonization resistance could be 
overcome subsequently facilitating infection induced 
immunpathological sequelae such as acute enterocol-
itis which is a key feature of human campylobacteriosis 
[31–33]. Given that C. jejuni and A. butzleri share taxo-
nomic relationships we used the gnotobiotic IL-10−/− 
mouse model to determine the pathogenic potential 
of A. butzleri and to investigate its host-interactions in 
the murine intestinal tract. Hereby, we focussed on the 
small intestines given that certain bacterial species use 
the ileal membranous epithelial cells (M cells) for inva-
sion and subsequent induction of inflammation [34]. To 
accomplish this, gnotobiotic IL-10−/− mice were pero-
rally infected with one of two different A. butzleri strains 
[19, 35]. Then, colonization properties alongside the 
intestinal tract, translocation of viable bacteria to distant 
extra-intestinal compartments, induction of histopatho-
logical changes including apoptosis and, finally, local (i.e. 
small intestinal) as well as systemic pro-inflammatory 
responses were analyzed.
Results
Abundance of A. butzleri in the intestinal tract 
following peroral infection of gnotobiotic IL‑10−/− mice
The induction of small intestinal and systemic immune 
responses were investigated in mice infected with the A. 
butzleri strains CCUG 30485 and C1. Both A. butzleri 
strains encode for all ten putative virulence genes and 
displayed adhesive and invasive phenotypes in human 
epithelial cell culture models [19]. The reference strain 
CCUG 30485 was initially isolated from a diseased 
patient [35], whereas the C1 strain was derived from fresh 
chicken meat [19]. In order to overcome physiological 
colonization resistance of mice harboring a conventional 
microbiota preventing from infection with pathogens, we 
generated gnotobiotic mice by depleting the intestinal 
microbiota following broad-spectrum antibiotic treat-
ment [30]. Previous C. jejuni infection studies revealed 
that the murine gnotobiotic IL-10−/− model is well suited 
not only to study pathogenic colonization properties, but 
also infection-induced immunopathological responses 
mimicking key features of human disease [31–33]. Fur-
thermore, given the taxonomic relationship of Arcobacter 
and Campylobacter, we applied the gnotobotic IL-10−/− 
model to unravel colonization and immunopathologi-
cal properties of A. butzleri in the present study. Given 
that C. jejuni induced non-self-limiting enterocolitis in 
gnotobiotic IL-10−/− mice within 6 days p.i. [31–33], we 
investigated potential immunopathological sequelae of A. 
Page 3 of 11Heimesaat et al. Gut Pathog  (2015) 7:28 
butzleri infection at day 6 p.i. and, additionally, to a later 
time point, namely day 16 p.i. Six and 16 days following 
peroral infection with 109 viable A. butzleri the respec-
tive isolates could be cultured from the small and large 
intestinal lumen with highest loads of up to 108 colony 
forming units (CFU) per g in the colon and approxi-
mately 104 CFU per g in the ileum of infected gnotobiotic 
IL-10−/− mice (Fig.  1). Colonization densities of either 
strain did not differ between day 6 and day 16 p.i. in the 
respective intestinal compartment. Hence, A. butzleri of 
either strain is able to stably establish alongside the intes-
tinal tract in the course of infection. Interestingly, mice 
did not exhibit any clinical signs of enteric disease such 
as wasting, diarrhea or occurence of blood in stool.
Macroscopic and microscopic aspects of small intestinal 
inflammatory sequelae in A. butzleri infected gnotobiotic 
IL‑10−/− mice
Given that intestinal inflammation is accompanied by 
significant shortening of the intestinal tract [31, 36], we 
determined small intestinal lengths at days of necropsy. 
Neither at day 6 nor at day 16 following A. butzleri infec-
tion with either strain, shortening of the small intestines 
could be observed when compared to uninfected control 
mice (not shown), further supporting an absence of acute 
infection-induced macroscopic disease.
We next surveyed potential microscopic intestinal 
sequelae of infection in hematoxylin & eosin (H&E) 
stained small intestinal paraffin sections applying a stand-
ardized histopathological scoring system (see “Meth-
ods”). Histopathological scores did not differ between 
naive and infected mice irrespective of the applied strain 
and the time point (day 6 and 16 p.i.; not shown).
We next assessed numbers of caspase-3+ cells within 
the small intestinal mucosa of infected mice given that 
apoptosis is a commonly used diagnostic marker in the 
histopathological evaluation and grading of intestinal dis-
ease [30] and a hallmark of C. jejuni induced enterocol-
itis in gnotobiotic IL-10−/− mice [31]. At day 16, but not 
earlier at day 6 following infection with the CCUG 30485 
or C1 strain, mice displayed higher apoptotic cells in the 
epithelial cells of the small intestinal mucosa as compared 
to naive control animals (p  <  0.05; Fig.  2a). Since Ki67 
comprises a nuclear protein necessary for cellular prolif-
eration [37], we quantitatively determined proliferating 
cells in small intestinal paraffin sections in situ. Following 
C1 strain infection only, gnotobiotic IL-10−/− mice dis-
played more Ki67+ small intestinal epithelial cells at day 
16 as compared to day 6 p.i. (p < 0.005; Fig. 2b).
Small intestinal influx of distinct immune cell populations 
in A. butzleri infected gnotobiotic IL‑10−/− mice
Given that recruitment of innate and adaptive immune 
cells as well as of effector cells to sites of inflammation 
is a hallmark of enteric infection such as campylobacteri-
osis [30], we next quantitatively assessed distinct immune 
cell populations by in  situ immunohistochemical stain-
ing of small intestinal paraffin sections. Irrespective of 
the A. butzleri strain, numbers of small intestinal CD3+ 
T lymphocytes increased 6 and 16 days following infec-
tion (p  <  0.05–0.005; Fig.  3a). Remarkably, numbers of 
T cells as well as of FOXP3+ regulatory T cells (Tregs) 
increased by more than twofold as early as 6 days follow-
ing CCUG 30485 strain infection (p < 0.005 and p < 0.05, 
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Fig. 1 Colonization of Arcobacter butzleri alongside the murine 
intestinal tract following peroral infection. Gnotobiotic IL-10−/− mice 
were generated by antibiotic treatment and orally infected either 
with a A. butzleri strain CCUG 30485 (circles) or b strain C1 (squares). 
A. butzleri loads were determined in luminal samples of duodenum, 
ileum and colon at day 6 p.i. (filled symbols) and day 16 p.i. (open 
symbols) as colony forming units (CFU) per gram sample. Medians 
(black bars) and numbers of mice harboring the pathogen out of the 
total number of analyzed animals (in parentheses) are indicated. Data 
shown were pooled from three independent experiments
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thereafter to a still elevated level (p < 0.05; Fig. 3a). Fur-
thermore, numbers of small intestinal B220+ B lympho-
cytes increased rather late (i.e. until day 16 p.i.) during 
A. butzleri C1 strain, but not CCUG 30485 strain infec-
tion (p < 0.005; Fig. 3c). The influx of macrophages and 
monocytes into the small intestinal tract upon A. but-
zleri infection, however, was not enhanced as indicated 
by comparable ileal F4/80+ cell numbers in infected and 
uninfected mice at either time point (Fig. 3d).
Small intestinal and systemic pro‑inflammatory cytokine 
secretion in A. butzleri infected gnotobiotic IL‑10−/− mice
We next determined the secretion of pro-inflammatory 
cytokines in supernatants of ex  vivo biopsies derived 
from ileum, mesenteric lymphnodes (MLNs) and spleen. 
At day 6, but not day 16 following A. butzleri infection 
with either strain, higher TNF and IL-6 levels could be 
detected in the small intestine as compared to naive 
mice (p < 0.005; Fig. 4a, b). Ileal MCP-1 concentrations 
increased upon CCUG 30485 strain infection until day 6 
(p < 0.05; Fig. 4c), and were higher at 6 days as compared 
to 16 days following C1 strain infection (p < 0.05; Fig. 4c). 
Furthermore, IFN-γ concentrations were elevated in 
small intestines as well as in MLNs as early as 6 days fol-
lowing CCUG 30485 strain infection (p < 0.005; Fig. 4d; 
p < 0.005; Fig. 5), but declined back to naive levels until 
day 16 p.i. (p  <  0.005; Fig.  4d; p  <  0.05; Fig.  5a). Strik-
ingly, this held also true for IFN-γ levels in spleens that 
increased 6 days, but not 16 days following CCUG 30485 
strain infection (p < 0.005; Fig. 5b), indicating that A. but-
zleri infection resulted not only in local but also systemic 
immune responses in a strain-dependent fashion. 
Taken together, despite absence of clinical symptoms 
of disease and stable colonization alongside the intesti-
nal tract, peroral A. butzleri infection led to small intes-
tinal apoptosis, induced influx of T and B cells as well 
as of Tregs to sites of infection and resulted in intesti-
nal and systemic pro-inflammatory cytokine responses. 
Taken together, these findings underline a distinct immu-
nopathogenic potential of A. butzleri in vivo.
Discussion
The pathogenic relevance of Arcobacter infections in 
humans is under current debate. Overall, solid epide-
miological data are rather scarce. One of the reasons 
might be that species identification by the currently 
established routine measures in conventional microbi-
ology laboratories is rather challenging. It is therefore 
highly likely that the reported cases—mostly sporadic 
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Fig. 2 Kinetics of apoptotic and proliferating cells in ileal tissue following murine A. butzleri infection. Gnotobiotic IL-10−/− mice were generated by 
antibiotic treatment and orally infected either with A. butzleri strain CCUG 30485 (circles) or strain C1 (squares). Uninfected gnotobiotic IL-10−/− mice 
served as negative control (black diamonds). The average numbers of apoptotic (positive for caspase-3, Casp3; a) and proliferating cells (positive 
for Ki67; b) from at least six high power fields (HPF, ×400 magnification) per animal were determined microscopically in immunohistochemically 
stained ileal section at day 6 p.i. (filled symbols) and day 16 p.i. (open symbols). Numbers of analyzed animals are given in parenthesis. Medians (black 
bars) and level of significance (p value) determined by Mann–Whitney U test are indicated. Data shown were pooled from three independent 
experiments
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highly under-representing the real prevalence [1]. Even-
though Campylobacter and Arcobacter are taxonomi-
cally related and, furthermore, in the meantime C. jejuni 
has established as the most commonly reported bacte-
rial etiological agent of diarrhea in developed countries 
outcompeting Salmonella [38], the scientific community 
did not undertake ambitious efforts to unravel poten-
cies of Arcobacter in inducing immunopathology in vivo. 
Results from the few studies to date, however, are rather 
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Fig. 3 Kinetics of immune cell infiltration in ileal tissue following murine A. butzleri infection. Gnotobiotic IL-10−/− mice were generated by anti-
biotic treatment and orally infected either with A. butzleri strain CCUG 30485 (circles) or strain C1 (squares). Uninfected gnotobiotic IL-10−/− mice 
served as negative control (black diamonds). The average number of cells positive for a CD3 (T lymphocytes). b FOXP3 (regulatory T cells, Tregs). c 
B220 (B lymphocytes) and d F4/80 (macrophages and monocytes) from at least six high power fields (HPF, ×400 magnification) per animal were 
determined microscopically in immunohistochemically stained ileal sections derived from mice at day 6 p.i. (filled symbols) and day 16 p.i. (open 
symbols). Numbers of analyzed animals are given in parentheses. Medians (black bars) and significance levels as determined by the Mann–Whitney U 
test are indicated. Data shown were pooled from three independent experiments
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the breed and/or on the respective A. butzleri strain 
under investigation [1]. To our knowledge, only one 
single Arcobacter infection study has been performed 
in mice so far demonstrating that following serial intra-
peritoneal passages in mice, the adherent capabilities of 
initially low-adherent A. butzleri strains were enhanced 
[39]. Previously, our group has established several murine 
C. jejuni infection models (reviewed in [40]). To assure 
proper pathogenic colonization of the murine gut, the 
microbiota needs to be modified to overcome the physio-
logical colonization resistance [30]. Among these models, 
gnotobiotic IL-10−/− mice, in which the intestinal micro-
biota was depleted by broad-spectrum antibiotic treat-
ment, develop acute enterocolitis within 1 week following 
oral C. jejuni infection mimicking key features of severe 
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Fig. 4 Kinetics of pro-inflammatory cytokine responses in the ileum following murine A. butzleri infection. Gnotobiotic IL-10−/− mice were gener-
ated by antibiotic treatment and orally infected either with A. butzleri strain CCUG 30485 (circles) or strain C1 (squares). Uninfected gnotobiotic 
IL-10−/− mice served as negative control (black diamonds). Concentrations (pg per mg ileal tissue) of a TNF, b IL-6, c MCP-1 and d IFN-γ were 
determined in supernatant of ex vivo ileal biopsies at day 6 p.i. (filled symbols) and day 16 p.i. (open symbols). Numbers of analyzed animals are given 
in parentheses. Medians (black bars) and significance levels as determined by the Mann–Whitney U test are indicated. Data shown were pooled from 
three independent experiments
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relationship between Arcobacter and Campylobacter we 
applied the gnotobiotic IL-10−/− mouse model to unravel 
the immunopathological impact of two A. butzleri strains 
derived from two different hosts (namely human and 
chicken) and the respective bacterial-host-interactions 
in the present study. Following peroral infection either 
A. butzleri strain could stably colonize the intestinal tract 
with comparable loads. Whereas the colon harbored the 
highest A. butzleri densities, approximately four orders 
of magnitude lower bacterial loads were detected in the 
ileal lumen. It is of note that mice did not exert any overt 
infection induced symptoms such as diarrhea or wast-
ing. This is somewhat surprising, however, given that the 
two A. butzleri strains have been shown to exert adhe-
sive and invasive properties in  vitro [19]. The absence 
of macroscopic signs of disease might also be attribut-
able to a lower pathogenic potential as compared to C. 
jejuni. This might indicate that the observed symptoms 
induced by A. butzleri in our gnotobiotic IL-10 defi-
cient mice mimic arcobacteriosis in humans, which is 
thought to cause milder disease symptoms as compared 
to human campylobacteriosis. However, infected mice 
developed increased small intestinal caspase-3+ apopto-
sis at day 16 p.i., and hence rather late in comparison to 
C. jejuni infection in the same murine model. However, 
this is in line with results from in vitro studies showing 
that A. butzleri induced apoptosis in intestinal epithelial 
cells [41]. Furthermore, in human macrophages A. but-
zleri infection resulted in a distinct pro-inflammatory 
response as indicated by highly upregulated expression 
levels of TNF, IL-6 and IL-12 (like in our in vivo study), 
whereas the anti-inflammatory cytokine IL-10 was mod-
erately upregulated. This is further underlining that the 
murine gnotobiotic IL-10−/− applied here is well suited 
to unravel pathogen-host-interactions. Despite subse-
quent activation of caspase-3, -7 and -8, macrophages 
survived A. butzleri infection without any signs of DNA 
damage pointing towards cellular counter-regulatory 
measures [42]. Given that in our study higher ileal apop-
totic as well as Ki67+ proliferating cell numbers could 
be observed at day 16 as compared to day 6 following C1 
strain infection, absence of macroscopic disease might 
have also been due to distinct counter-regulatory meas-
ures despite stable bacterial colonization. Despite the 
absence of macroscopic disease symptoms, A. butzleri 
induced a prominent influx of pro-inflammatory innate 
and adaptive immune cell populations such as T and B 
cells as well as Tregs into the small intestinal mucosa 
and lamina propria. In another in vivo study, A. butzleri 
could be cultured from the small intestines of Cesarean-
derived neonatal piglets [27]. The strain exerted invasive 
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Fig. 5 Kinetic of IFN-γ responses in ex vivo biopsies of mesenteric lymphnodes and spleens of A. butzleri infected mice. Gnotobiotic IL-10−/− mice 
were generated by antibiotic treatment and orally infected either with A. butzleri strain CCUG 30485 (circles) or strain C1 (squares). Uninfected 
gnotobiotic IL-10−/− mice served as negative control (black diamonds). Concentrations (pg per mg of total protein) of IFN-γ were determined in 
supernatant of ex vivo biopsies derived from a mesenteric lymphnodes (MLNs) and b spleens at day 6 p.i. (filled symbols) and day 16 p.i. (open sym-
bols). Numbers of analyzed animals are given in parentheses. Medians (black bars) and significance levels as determined by the Mann–Whitney U test 
are indicated. Data shown were pooled from three independent experiments
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from extra-intestinal organs including kidney, lung and 
brain. Also in our study, the inflammatory responses fol-
lowing peroral A. butzleri infection were not restricted 
to the intestinal tract, since IFN-γ levels were not only 
elevated in ilea and MLNs, but also in spleens of CCUG 
30485 strain infected mice early in the course of disease. 
Notably, we were not able to isolate viable pathogens 
from extra-intestinal compartments including the spleen 
of infected mice by direct plating. Except for reddening 
of the ileal mucosa in single piglets, neither gross nor 
microscopic signs could be observed in the small intes-
tinal tract of A. butzleri infected neonatal piglets [27]. In 
another in vivo study, albino rats presented with self-lim-
iting diarrhea 5 days following peroral A. butzleri infec-
tion that was accompanied with leukocytic infiltrates in 
the intestinal lamina propria [43]. These results are well 
in line with our data given that increased numbers of 
ileal T and B cells, but also of regulatory T cells could be 
observed in the course of A. butzleri infection of gnotobi-
otic IL-10−/− mice.
The rather heterogenous outcome of A. butzleri 
infection in  vivo might be attributed to a plethora of 
distinct contextual factors such as host-related differ-
ences including animal species, age, immune status and 
microbiota composition on the host side and bacte-
rial strain-dependent factors [1]. In our study, distinct 
strain-dependent differences in pathogen-host-interac-
tion could be observed in infected gnotobiotic IL-10−/− 
mice. Given that Arcobacter strains express variable 
lipopolysaccharide (LPS) or lipooligosacchardie (LOS) 
structures, this might determine whether the respective 
strains rather act as commensals or as pathogens in vivo. 
Previously, we have demonstrated that C. jejuni infection 
is mediated by TLR-4-dependent signalling of bacterial 
LOS [30, 31]. Accordingly, we are currently investigating 
potential TLR-4-dependent intestinal, extra-intestinal as 
well as systemic immunopathological features of arco-
bacteriosis in murine in vivo models.
Conclusion
In conclusion, in perorally infected gnotobiotic IL-10−/− 
mice A. butzleri induce small intestinal and systemic pro-
inflammatory immune responses in a strain-dependent 
fashion. The immunopathogenic potential of A. butzleri 
in  vivo indicates that the murine model applied here is 
well suited to further unravel the molecular mecha-




All animal experiments were conducted according to the 
European Guidelines for animal welfare (2010/63/EU) 
with approval of the commission for animal experiments 
headed by the “Landesamt für Gesundheit und Soziales” 
(LaGeSo, Berlin, registration number G0184/12). Animal 
welfare was monitored twice daily by assessment of clini-
cal conditions.
Mice
IL-10−/− mice (in C57BL/6j background, B6) were bred 
and maintained in the facilities of the “Forschungsein-
richtungen für Experimentelle Medizin” (FEM, Charité-
Universitätsmedizin, Berlin, Germany) under specific 
pathogen-free (SPF) conditions.
Gnotobiotic IL-10−/− mice (with a virtually depleted 
gastrointestinal microbiota) were generated following 
broad-spectrum antibiotic treatment as described ear-
lier [31, 36]. In brief, mice were transferred to sterile 
cages and treated by adding ampicillin/sulbactam (1 g/L; 
Pfizer, Berlin, Germany), vancomycin (500 mg/L; Hexal, 
Holzkirchen, Germany), ciprofloxacin (200 mg/L; Hexal), 
imipenem (250 mg/L; Fresenius Kabi, Graz, Austria), and 
metronidazole (1  g/L; Braun, Melsungen, Germany) to 
the drinking water ad  libitum starting at 3 weeks of age 
immediately after weaning and continued for 3  months 
before the infection experiment [33]. Three days prior 
infection, the antibiotic cocktail was replaced by sterile 
tap water (ad libitum). Mice were continuously kept in a 
sterile environment (autoclaved food and tap water) and 
handled under strict antiseptic conditions.
Arcobacter butzleri infection of mice
Gnotobiotic IL-10−/− mice were perorally infected with 
approximately 109 viable CFU of two different Arcobacter 
butzleri strains either (CCUG 30485 or C1 strain, respec-
tively) by gavage in a total volume of 0.3 mL phosphate 
buffered saline (PBS) on two consecutive days (day 0 and 
day 1). Naive age- and sex-matched gnotobiotic IL-10−/− 
mice served as uninfected controls.
The A. butzleri reference strain CCUG 30485 was ini-
tially isolated from a fecal sample derived from a diar-
rheal patient [35], whereas the C1 strain was isolated 
from fresh chicken meat [19]. Both A. butzleri strains 
were grown on Karmali-Agar (Oxoid, Wesel, Germany) 
for 2 days at 37 °C under microaerobic conditions using 
CampyGen gas packs (Oxoid).
Clinical score
To assess clinical signs of A. butzleri infection on a daily 
basis, a standardized cumulative clinical score (maxi-
mum 12 points), addressing the occurrence of blood in 
feces (0: no blood; 2: microscopic detection of blood by 
the Guajac method using Haemoccult, Beckman Coulter/
PCD, Krefeld, Germany; 4: overt blood visible), diarrhea 
(0: formed feces; 2: pasty feces; 4: liquid feces), and the 
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clinical aspect (0: normal; 2: ruffled fur, less locomotion; 
4: isolation, severely compromised locomotion, pre-final 
aspect) was used [31].
Sampling procedures
Mice were sacrificed by isoflurane treatment (Abbott, 
Greifswald, Germany) on day 6 or day 16 p.i.. Tissue sam-
ples from MLNs, spleen, and ileum were removed under 
sterile conditions. Absolute small intestinal lengths were 
determined by measuring the distances from the transi-
tion of the stomach to the duodenum to the very distal 
terminal ileum by a ruler. Ileal ex vivo biopsies from each 
mouse were collected in parallel for immunohistochemi-
cal, microbiological, and immunological analyses. Immu-
nohistopathological changes were determined in ileal 
samples immediately fixed in 5  % formalin and embed-
ded in paraffin. Sections (5 μm) were stained with H&E 
or respective antibodies for in situ immunohistochemis-
try as described earlier [33].
Histopathological grading of small intestinal lesions
To evaluate the severity of small intestinal histopatho-
logical lesions, an established scoring scheme [44] with 
minor modifications was applied. In detail, the compo-
sition of the immune cell infiltrates (0: none; 1: mono-
nuclear cells; 2: mononuclear cell dominated, fewer 
neutrophils; 3: neutrophil dominated, fewer mononuclear 
cells), quantity of the immune cell infiltrates (0: none; 1: 
mild; 2: moderate; 3: severe), vertical extent of inflam-
mation (0: none; 1: mucosa; 2: mucosa and submucosa; 
3: transmural), and horizontal extent of inflammation (0: 
no; 1: focal; 2: multifocal; 3: multifocal-coalescent; 4: dif-
fuse) were assessed. The cumulative histologic scoring 
ranged from 0 to 13 for ileal samples.
Immunohistochemistry
In situ immunohistochemical analysis of ileal paraffin 
sections was performed as described previously [30, 31, 
45–47]. Primary antibodies against cleaved caspase-3 
(Asp175, Cell Signaling, Beverly, MA, USA, 1:200), 
Ki67 (TEC3, Dako, Denmark, 1:100), CD3 (#N1580, 
Dako, 1:10), FOXP3 (FJK-16  s, eBioscience, San Diego, 
CA, USA, 1:100), B220 (eBioscience, 1:200), and F4/80 
(# 14-4801, clone BM8, eBioscience, 1:50), were used. 
For each animal, the average number of positively 
stained cells within at least six high power fields (HPF, 
0.287 mm2, 400× magnification) were determined micro-
scopically by a double-blinded investigator.
Quantitative analysis of Arcobacter butzleri
Viable A. butzleri were detected in feces or at time of 
necropsy (day 6 or 16 p.i.) in luminal samples taken from 
the duodenum, ileum or colon, dissolved in sterile PBS 
and cultured in serial dilutions on Karmali- and Colum-
bia-Agar supplemented with 5  % sheep blood (Oxoid) 
in parallel for 2 days at 37 °C under microaerobic condi-
tions using CampyGen gas packs (Oxoid). To quantify 
bacterial translocation, MLNs and spleen (≈1 cm2) were 
homogenized in 1 mL sterile PBS, streaked onto Karmali-
Agar and cultivated accordingly. The respective weights 
of fecal or tissue samples were determined by the differ-
ence of the sample weights before and after asservation. 
The detection limit of viable pathogens was ≈100 colony 
forming units (CFU) per g.
Cytokine detection in culture supernatants of ex vivo 
biopsies taken from ileum, mesenteric lymphnodes 
and spleen
Ileal ex vivo biopsies were cut longitudinally and washed 
in PBS. Spleen, MLNs or strips of approximately 1  cm2 
ileum were placed in 24-flat-bottom well culture plates 
(Nunc, Wiesbaden, Germany) containing 500 μL serum-
free RPMI 1640 medium (Gibco, life technologies, Pais-
ley, UK) supplemented with penicillin (100  U/mL) and 
streptomycin (100 µg/mL; PAA Laboratories). After 18 h 
at 37  °C, culture supernatants were tested for IFN-γ, 
TNF, MCP-1, IL-6  and IL-12p70 by the Mouse Inflam-
mation Cytometric Bead Assay (CBA; BD Biosciences, 
San Jose, CA, USA) on a BD FACSCanto II flow cytom-
eter (BD Biosciences). Nitric oxide (NO) was determined 
by Griess reaction as described earlier [36].
Statistical analysis
Medians and levels of significance were determined using 
Mann–Whitney test (GraphPad Prism v5, La Jolla, CA, 
USA). Two-sided probability (P) values ≤0.05 were con-
sidered significant. Experiments were reproduced twice.
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